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A ccording to U.S. cancer statistics, prostate cancer has been the most commonly diagnosed cancer and the second leading cause of cancer deaths in 
American men.’ To improve the diagnosis and the clinical 
management of this disease and to prevent its future oc- 
currence, a number of strategies need to be implemented. 
One strategy is to develop relevant animal models and 
tissue culture systems that closely mimic clinical condi- 
tions of human prostate cancer. This could help us de- 
velop new diagnostic tools to distinguish the indolent from 
the virulent forms of the disease and to design novel thera- 
peutic approaches to target this disease. Such efforts 
could improve the prevention, diagnosis, prognosis, and 
treatment of prostate cancer. 
This minireview summarizes the relevant animal mod- 
els and tissue culture systems with comments from leading 
authorities who made the original contributions to the 
prostate cancer model systems described. This review is 
intended to: (1) summarize pertinent published literature 
on the nature of the prostate cancer model described; (2) 
discuss the strengths and the limitations of the model sys- 
tems in answering important biological questions facing 
prostate cancer research; and (3) provide source informa- 
tion about where these prostate cancer models can be 
obtained. The contributing authors have a number of 
goals. First, we hope that this article will provide relevant 
and accurate background information to an increasing 
number of new investigators whose research has begun to 
focus sharply on prostate cancer biology and therapy. Sec- 
ond, we hope to attract the interest of new investigators to 
devote their talents to this fertile area of cancer research. 
Finally, we believe that using experimental model-based 
prostate cancer research will increase rapidly our under- 
standing of the fundamental aspects of prostate cancer 
biology, including its development, progression, differen- 
tiation, and senescence. The basic knowledge gained from 
these fundamental studies can be translated to the clinic to 
improve our ability to prevent, diagnose, prognose, and 
treat patients with prostate cancer. 
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